 "JB Chemicals & Pharmaceuticals Q1 net up 26% at Rs 49.85 crore")
JB Chemicals & Pharmaceuticals has reported 25.78 per cent rise in standalone net profit at Rs 49.85 crore for the first quarter ended June 30.
The company had posted a net profit of Rs 39.63 crore for the corresponding period of the previous financial year.
Its total income from operations rose to Rs 309.22 crore for the quarter under consideration, as against Rs 284.2 crore for the year-ago period.
During the quarter, the company's domestic formulations sales grew 12.50 per cent to Rs 128.78 crore, while overall formulations export registered a growth of 2.54 per cent to Rs 131.08 crore.
Shares of JB Chemicals & Pharmaceuticals were trading at Rs 346.70 per scrip on BSE, up 11.14 per cent, from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%